April 28, 2025 03:05 AM EDTUpdated 08:53 AM

Keytruda around head and neck cancer surgery cuts chance of disease coming back

Lei Lei Wu

News Reporter

CHICAGO — Merck’s widely used cancer drug Keytruda could soon be getting another indication, this time for use before and after surgery for head and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Keytruda around head and neck cancer surgery cuts chance of disease coming back

Lei Lei Wu

News Reporter

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data

France stops Valneva's chikungunya vaccine rollout in over 65s after safety issue

Exclusive: Can AI replace animal testing? A new biotech launches to find out

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

European regulators recommend new drugs from Vertex, Amgen and Jazz

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Keytru­da around head and neck can­cer surgery cuts chance of dis­ease com­ing back

News Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Keytruda around head and neck cancer surgery cuts chance of disease coming back